NF2 and diabetic kidney disease: This suggests that hucMSC-EVs can ameliorate renal fibrosis in DKD by inhibiting the function of miR-146b-5p and regulating the Merlin/YAP signaling pathway in both in vivo and in vitro DKD models (Figure 6).